Upgrades Hold Buy X

EW Edwards Lifesciences

Stifel

$75 $90

Downgrades Peer Perform Underperform X

EW Edwards Lifesciences

Wolfe Research

$60

Upgrades Neutral Buy X

EW Edwards Lifesciences

BofA Securities

Resumed Equal-Weight X

EW Edwards Lifesciences

Morgan Stanley

$70

Downgrades Buy Hold X

EW Edwards Lifesciences

Jefferies

$85 $70

Upgrades Neutral Outperform X

EW Edwards Lifesciences

Daiwa Securities

Upgrades Underperform Peer Perform X

EW Edwards Lifesciences

Wolfe Research

Downgrades Buy Neutral X

EW Edwards Lifesciences

BofA Securities

$105 $75

Downgrades Overweight Neutral X

EW Edwards Lifesciences

JP Morgan

$105 $72

Downgrades Outperform Neutral X

EW Edwards Lifesciences

Robert W. Baird

$102 $70

Downgrades Buy Hold X

EW Edwards Lifesciences

TD Cowen

$100 $70

Downgrades Buy Hold X

EW Edwards Lifesciences

Truist

$110 $82

Initiated Buy X

EW Edwards Lifesciences

Goldman

$107

Upgrades Neutral Buy X

EW Edwards Lifesciences

Citigroup

$98 $105

Upgrades Hold Buy X

EW Edwards Lifesciences

Deutsche Bank

Upgrades Neutral Buy X

EW Edwards Lifesciences

BofA Securities

Upgrades Eq Weight Overweight X

EW Edwards Lifesciences

Wells Fargo

$94

Downgrades Outperform In-line X

EW Edwards Lifesciences

Evercore ISI

$80 $77

Downgrades Buy Neutral X

EW Edwards Lifesciences

Citigroup

Downgrades Peer Perform Underperform X

EW Edwards Lifesciences

Wolfe Research

$57

Upgrades Perform Outperform X

EW Edwards Lifesciences

Oppenheimer

$90

Initiated Outperform X

EW Edwards Lifesciences

Robert W. Baird

$107

Resumed Overweight X

EW Edwards Lifesciences

Morgan Stanley

$102

Initiated Neutral X

EW Edwards Lifesciences

UBS

$84

Downgrades Overweight Eq Weight X

EW Edwards Lifesciences

Wells Fargo

$97 $78

Downgrades Outperform Mkt Perform X

EW Edwards Lifesciences

Raymond James

Downgrades Outperform Underperform X

EW Edwards Lifesciences

Bernstein

$95 $66

Downgrades Overweight Neutral X

EW Edwards Lifesciences

Piper Sandler

$95 $80

Downgrades Buy Hold X

EW Edwards Lifesciences

Stifel

$95 $75

Downgrades Outperform Perform X

EW Edwards Lifesciences

Oppenheimer

Initiated Buy X

EW Edwards Lifesciences

Mizuho

$100

Initiated Overweight X

EW Edwards Lifesciences

Barclays

$96

Initiated Buy X

EW Edwards Lifesciences

Jefferies

$110

Downgrades Buy Hold X

EW Edwards Lifesciences

Canaccord Genuity

$115 $106

Initiated Buy X

EW Edwards Lifesciences

Truist

$145

Upgrades Mkt Perform Outperform X

EW Edwards Lifesciences

Bernstein

$132 $135

Upgrades Neutral Buy X

EW Edwards Lifesciences

UBS

$121 $126

Reiterated Buy X

EW Edwards Lifesciences

Citigroup

$142 $138

Reiterated Outperform X

EW Edwards Lifesciences

Evercore ISI

$130 $122

Reiterated Outperform X

EW Edwards Lifesciences

Raymond James

$134 $126

Reiterated Buy X

EW Edwards Lifesciences

Stifel

$132 $120

Reiterated Neutral X

EW Edwards Lifesciences

UBS

$125 $121

Upgrades Neutral Overweight X

EW Edwards Lifesciences

JP Morgan

$114 $140

Upgrades Neutral Buy X

EW Edwards Lifesciences

Citigroup

$120 $142

Initiated Outperform X

EW Edwards Lifesciences

RBC Capital Mkts

$142

Reiterated Buy X

EW Edwards Lifesciences

Canaccord Genuity

$103 $124

Reiterated Hold X

EW Edwards Lifesciences

Deutsche Bank

$84 $113

Reiterated Buy X

EW Edwards Lifesciences

Jefferies

$110 $130

Reiterated Overweight X

EW Edwards Lifesciences

Morgan Stanley

$108 $135

Reiterated Outperform X

EW Edwards Lifesciences

Oppenheimer

$97 $120

Reiterated Buy X

EW Edwards Lifesciences

Stifel

$103 $120

Reiterated Neutral X

EW Edwards Lifesciences

UBS

$98 $115

Reiterated Equal Weight X

EW Edwards Lifesciences

Wells Fargo

$93 $115

Initiated Overweight X

EW Edwards Lifesciences

Barclays

$110

Initiated Neutral X

EW Edwards Lifesciences

Atlantic Equities

$85

Upgrades In-line Outperform X

EW Edwards Lifesciences

Evercore ISI

Reiterated Buy X

EW Edwards Lifesciences

BofA/Merrill

$215 $225

Reiterated Buy X

EW Edwards Lifesciences

Canaccord Genuity

$190 $215

Upgrades Neutral Buy X

EW Edwards Lifesciences

BofA/Merrill

Initiated Neutral X

EW Edwards Lifesciences

UBS

$165

Initiated Underweight X

EW Edwards Lifesciences

Barclays

$143

Downgrades Buy Neutral X

EW Edwards Lifesciences

BofA/Merrill

Downgrades Buy Neutral X

EW Edwards Lifesciences

Guggenheim

Initiated Mkt Perform X

EW Edwards Lifesciences

Bernstein

$165

Initiated Outperform X

EW Edwards Lifesciences

Raymond James

$152

Downgrades Outperform Mkt Perform X

EW Edwards Lifesciences

Northland Capital

Reiterated Buy X

EW Edwards Lifesciences

Canaccord Genuity

$140 $174

EW  Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.